Gunther Birznieks - Net Worth and Insider Trading

Gunther Birznieks Net Worth

The estimated net worth of Gunther Birznieks is at least $1 Million dollars as of 2024-04-29. Gunther Birznieks is the SVP, Business Development of Vanda Pharmaceuticals Inc and owns about 313,569 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $1 Million. Details can be seen in Gunther Birznieks's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gunther Birznieks has not made any transactions after 2024-03-05 and currently still holds the listed stock(s).

Transaction Summary of Gunther Birznieks

To

Gunther Birznieks Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gunther Birznieks owns 1 companies in total, including Vanda Pharmaceuticals Inc (VNDA) .

Click here to see the complete history of Gunther Birznieks’s form 4 insider trades.

Insider Ownership Summary of Gunther Birznieks

Ticker Comapny Transaction Date Type of Owner
VNDA Vanda Pharmaceuticals Inc 2024-03-05 SVP & Business Development

Gunther Birznieks Latest Holdings Summary

Gunther Birznieks currently owns a total of 1 stock. Gunther Birznieks owns 313,569 shares of Vanda Pharmaceuticals Inc (VNDA) as of March 5, 2024, with a value of $1 Million.

Latest Holdings of Gunther Birznieks

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
VNDA Vanda Pharmaceuticals Inc 2024-03-05 313,569 4.62 1,448,689

Holding Weightings of Gunther Birznieks


Gunther Birznieks Form 4 Trading Tracker

According to the SEC Form 4 filings, Gunther Birznieks has made a total of 5 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 17,411 shares on March 5, 2024, which brought Gunther Birznieks around $73,300.

Insider Trading History of Gunther Birznieks

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gunther Birznieks Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Gunther Birznieks Ownership Network

Ownership Network List of Gunther Birznieks

No Data

Ownership Network Relation of Gunther Birznieks


Gunther Birznieks Owned Company Details

What does Vanda Pharmaceuticals Inc do?

Who are the key executives at Vanda Pharmaceuticals Inc?

Gunther Birznieks is the SVP & Business Development of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include SVP & General Counsel Timothy Williams , VP & Acting CFO & Treasurer Kevin Patrick Moran , and SVP & Chief Marketing Officer Joakim Wijkstrom .

Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary

Over the past 18 months, Gunther Birznieks made 2 insider transaction in Vanda Pharmaceuticals Inc (VNDA) with a net sale of 34,188. Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vanda Pharmaceuticals Inc Insider Transactions

No Available Data

Gunther Birznieks Mailing Address

Above is the net worth, insider trading, and ownership report for Gunther Birznieks. You might contact Gunther Birznieks via mailing address: 2200 Pennsylvania Ave Nw, Suite 300e, Washington Dc 20037.

Discussions on Gunther Birznieks

No discussions yet.